arrow
O

Osman Sütçüoğlu

Gazi University
H指数:11
被引数:376

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline 25-Hydroxyvitamin D and Progression-Free Survival in de novo mHSPC: Prognostic Model Development and External Validation

基线25-羟基维生素D与去势抵抗性前列腺癌中mHSPC患者的无进展生存期:预后模型构建与外部验证

2026-10-060
OAAI
Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

残余胆固醇炎症指数预测乳腺癌新辅助治疗病理完全缓解:一项多中心外部验证研究

Breast
IF7.9
2026-09-220
OA
Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial)

肢体加压疗法与妇科癌症患者化疗诱导的周围神经病变:一项前瞻性自身对照研究(NEURO-GLOVE试验)

2026-06-180
OAAI
Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey

土耳其多中心回顾性队列研究:接受免疫检查点抑制剂最后一剂治疗后30天的实际死亡率

2026-06-060
OA
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

局部晚期直肠癌中总新辅助疗法的真实世界有效性:一项多中心回顾性研究

2026-03-230
OAAI
Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

与健康相关的生活质量和免疫检查点抑制剂治疗长期存活者的心理社会结局:一项全国性多中心研究

2025-12-100
OA
Induction chemotherapy followed by definitive chemoradiation in patients with inoperable esophageal squamous cell carcinoma: a multicenter retrospective study

不可手术食管鳞状细胞癌患者中诱导化疗后行根治性放化疗:一项多中心回顾性研究

2025-11-180
OAAI
Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study

晚期子宫平滑肌肉瘤中多柔比星–异环磷酰胺与吉西他滨–多西他赛方案的真实世界比较:一项多中心回顾性研究

2025-11-170
OAAI
Impact of sarcopenia on paclitaxel-induced peripheral neuropathy in early-stage breast cancer: a prospective observational study (the neuro-sarc study)

肌少症对早期乳腺癌患者紫杉醇诱导的周围神经病变的影响:一项前瞻性观察研究(神经-肌少症研究)

2025-11-140
PRE
Efficacy and safety of doxorubicin–ifosfamide versus gemcitabine–docetaxel as first-line therapy in advanced nonuterine leiomyosarcoma: A multicenter real-world study

多中心真实世界研究:多柔比星–异环磷酰胺方案与吉西他滨–多西他赛方案作为一线疗法治疗晚期非子宫平滑肌肉瘤的疗效与安全性比较

2025-10-280
PRE
Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)

使用炎症、营养和肌肉减少症相关标志物预测局部晚期直肠癌的病理反应:一项基于回归和人工智能的分析(CINR-AI研究)

2025-10-160
PRE